Ayesha Patil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayesha Patil has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Chase Paulson
John A. Moran Eye Center, Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT 84113, USA
3 shared publications - Matthew Conley
Department of Ophthalmology University of Utah School of Medicine Salt Lake City Utah USA
3 shared publications - Barbara Wirostko
John A. Moran Eye Center, Ophthalmology & Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT 84113, USA
2 shared publications Chase Paulson
Department of Ophthalmology University of Utah School of Medicine Salt Lake City Utah USA
2 shared publicationsChristian Pompoco
University of Utah Health John A. Moran Eye Center Salt Lake City Utah USA
2 shared publicationsCole Swiston
University of Utah Health John A. Moran Eye Center Salt Lake City Utah USA
2 shared publications
Latest Publications
- Open Access
- 11 November 2024
- Published by MDPI AG in Journal of Clinical & Translational Ophthalmology
- Vol. 2 (4) , 140-154
Risk of Age-Related Macular Degeneration in Patients with Exfoliation Syndrome: The Utah Project on Exfoliation Syndrome (UPEXS)
Objective: To investigate any relationships between exfoliation syndrome or exfoliation glaucoma and age-related macular degeneration utilizing the Utah population database. Design: This was a retrospective, case–control cohort study. Subjects, Participants, and/or Controls: We identified 3405 patients diagnosed with exfoliation syndrome (XFS) or exfoliation glaucoma (XFG) during a dilated eye exam within the UHealth system from 1996 to 2021, whose dry or wet age-related macular degeneration (AMD) status was assessed. A population-based control pool of 257,714 UHealth patients with no XFS/XFG diagnosis and a dilated eye exam history from 1996 to 2021 was compiled, with its patients randomly selected and individually matched 3:1 to cases based on sex and age at index diagnosis of their respective case. Methods: A covariate analysis was performed of characteristics and risk factors associated with XFS/XFG, which included race/ethnicity, residence location, partner/marital status, and family history of XFS/XFG, obesity, tobacco use, alcohol use, osteoporosis/vitamin D deficiency, primary/essential hypertension, ocular hypertension, and cataract surgery. Main Outcome Measure: We studied the trends of non-exudative (dry) or exudative (wet) AMD in a large Utah population study of XFS/XFG patients and controls. Results: Of 3396 XFS/XFG patients, as well as 10,179 individually matched 3:1 control patients, 64% were female and the average age of XFS onset was 74.3 yrs. In a univariate model, we observed a very modest increased risk of wet AMD in XFS/XFG patients (odds ratio, OR = 1.14, 95% confidence interval (CI) 0.99–1.32), which did not achieve statistical significance (p = 0.07). After adjusting for the main effects of potential confounders, there was no greater presentation of AMD in XFS/XFG patients when compared with controls (dry AMD: OR = 0.94, 95% CI 0.85–1.05, p = 031; wet AMD: OR = 0.98, 95% CI 0.83–1.14, p = 0.76). In XFS/XFG patients compared to controls, the risk of having cataract surgery was elevated (OR = 2.39, 95% CI 2.18–2.62). However, after accounting for an interaction with AMD, XFS/XFG patients who underwent cataract surgery did not exhibit an increased risk of either dry or wet AMD (dry AMD: OR = 0.91, 95% CI 0.80–1.03; wet AMD: OR = 0.89, 95% CI 0.75–1.07). The risk of AMD in XFS/XFG patients vs. controls showed no association with osteoporosis/vitamin D deficiency for dry (OR 0.78 95% CI 0.66–0.92 p = 0.004) or wet AMD (OR = 0.72 95% CI 0.56–0.92 p = 0.01), while we found a borderline positive association with both dry and wet AMD if they had osteoporosis/vitamin D deficiency. Conclusion: Using the Utah Population Database, we found that a cataract surgery history significantly impacts the association between AMD and XFS, and that vitamin D deficiency/osteoporosis is a significant confounder of the association. However, no direct association between XFS and AMD was found in this study.
- 11 November 2024
- Published by MDPI AG in Journal of Clinical & Translational Ophthalmology
- Vol. 2 (4) , 140-154
Open AccessRisk of Age-Related Macular Degeneration in Patients with Exfoliation Syndrome: The Utah Project on Exfoliation Syndrome (UPEXS)
Objective: To investigate any relationships between exfoliation syndrome or exfoliation glaucoma and age-related macular degeneration utilizing the Utah population database. Design: This was a retrospective, case–control cohort study. Subjects, Participants, and/or Controls: We identified 3405 patients diagnosed with exfoliation syndrome (XFS) or exfoliation glaucoma (XFG) during a dilated eye exam within the UHealth system from 1996 to 2021, whose dry or wet age-related macular degeneration (AMD) status was assessed. A population-based control pool of 257,714 UHealth patients with no XFS/XFG diagnosis and a dilated eye exam history from 1996 to 2021 was compiled, with its patients randomly selected and individually matched 3:1 to cases based on sex and age at index diagnosis of their respective case. Methods: A covariate analysis was performed of characteristics and risk factors associated with XFS/XFG, which included race/ethnicity, residence location, partner/marital status, and family history of XFS/XFG, obesity, tobacco use, alcohol use, osteoporosis/vitamin D deficiency, primary/essential hypertension, ocular hypertension, and cataract surgery. Main Outcome Measure: We studied the trends of non-exudative (dry) or exudative (wet) AMD in a large Utah population study of XFS/XFG patients and controls. Results: Of 3396 XFS/XFG patients, as well as 10,179 individually matched 3:1 control patients, 64% were female and the average age of XFS onset was 74.3 yrs. In a univariate model, we observed a very modest increased risk of wet AMD in XFS/XFG patients (odds ratio, OR = 1.14, 95% confidence interval (CI) 0.99–1.32), which did not achieve statistical significance (p = 0.07). After adjusting for the main effects of potential confounders, there was no greater presentation of AMD in XFS/XFG patients when compared with controls (dry AMD: OR = 0.94, 95% CI 0.85–1.05, p = 031; wet AMD: OR = 0.98, 95% CI 0.83–1.14, p = 0.76). In XFS/XFG patients compared to controls, the risk of having cataract surgery was elevated (OR = 2.39, 95% CI 2.18–2.62). However, after accounting for an interaction with AMD, XFS/XFG patients who underwent cataract surgery did not exhibit an increased risk of either dry or wet AMD (dry AMD: OR = 0.91, 95% CI 0.80–1.03; wet AMD: OR = 0.89, 95% CI 0.75–1.07). The risk of AMD in XFS/XFG patients vs. controls showed no association with osteoporosis/vitamin D deficiency for dry (OR 0.78 95% CI 0.66–0.92 p = 0.004) or wet AMD (OR = 0.72 95% CI 0.56–0.92 p = 0.01), while we found a borderline positive association with both dry and wet AMD if they had osteoporosis/vitamin D deficiency. Conclusion: Using the Utah Population Database, we found that a cataract surgery history significantly impacts the association between AMD and XFS, and that vitamin D deficiency/osteoporosis is a significant confounder of the association. However, no direct association between XFS and AMD was found in this study.
- Open Access
- 7 November 2024
- Published by Association of University Professors of Ophthalmology in Journal of Academic Ophthalmology
- Vol. 16 (2) , 4
Gender representation of presenters at American Academy of Ophthalmology conferences from 2004-2019
Importance: Gender equity is an important topic in medicine and accurate trends are essential to evaluate historical, current, and future trends. Objective: To describe changes in gender representation at American Academy of Ophthalmology (AAO) meetings from 2004 to 2019. Participants: Presenters at the American Academy of Ophthalmology meetings from 2004 to 2019. Design & Setting: This is a retrospective cross-sectional study. Data was extracted using AAO annual and subspecialty meeting archives for every third year between 2004 and 2019. Sessions were stratified by category and subspecialty. Poster sessions were excluded. Gender was considered binary and determined using pronouns or photographs from professional websites when available and the gender-api name tool when individual information was not available. Main outcome measures: Proportion of gender of the presenters at the American Academy of Ophthalmology within respective specialties with a focus on surgical vs clinical sessions. Results: The proportion of female presenters at AAO meetings increased between 2004 and 2019 from 13% to 29%. The largest changes were observed for oncology (net +28%, 1.85%/year increase, OR 1.09) and oculoplastics (+25%, 1.66%/year increase, OR 1.106). For surgical sessions, the increase in proportion of female speakers fell short of the overall increase in representation in comprehensive (+16% overall vs. +13% for surgical sessions), glaucoma (11% vs. 7%), and pediatrics (+17% vs. -1%). The increase in female representation among surgical session presenters did not exceed the overall increase for any subspecialty. For clinical sessions, the proportion of female leaders exceeded the overall increase in cornea (20% cornea vs. 13% overall), neuro-ophthalmology (15% vs. 9%), and pediatrics (35% vs. 17%). Conclusions: Female representation among presenters at the AAO annual and subspecialty meetings increased between 2004 and 2019 for all subspecialties. For many subspecialties, there was a proportionally slower rate of increase in female representation among surgical session presenters and faster rate of increase for clinical sessions.
- 7 November 2024
- Published by Association of University Professors of Ophthalmology in Journal of Academic Ophthalmology
- Vol. 16 (2) , 4
Open AccessGender representation of presenters at American Academy of Ophthalmology conferences from 2004-2019
Importance: Gender equity is an important topic in medicine and accurate trends are essential to evaluate historical, current, and future trends. Objective: To describe changes in gender representation at American Academy of Ophthalmology (AAO) meetings from 2004 to 2019. Participants: Presenters at the American Academy of Ophthalmology meetings from 2004 to 2019. Design & Setting: This is a retrospective cross-sectional study. Data was extracted using AAO annual and subspecialty meeting archives for every third year between 2004 and 2019. Sessions were stratified by category and subspecialty. Poster sessions were excluded. Gender was considered binary and determined using pronouns or photographs from professional websites when available and the gender-api name tool when individual information was not available. Main outcome measures: Proportion of gender of the presenters at the American Academy of Ophthalmology within respective specialties with a focus on surgical vs clinical sessions. Results: The proportion of female presenters at AAO meetings increased between 2004 and 2019 from 13% to 29%. The largest changes were observed for oncology (net +28%, 1.85%/year increase, OR 1.09) and oculoplastics (+25%, 1.66%/year increase, OR 1.106). For surgical sessions, the increase in proportion of female speakers fell short of the overall increase in representation in comprehensive (+16% overall vs. +13% for surgical sessions), glaucoma (11% vs. 7%), and pediatrics (+17% vs. -1%). The increase in female representation among surgical session presenters did not exceed the overall increase for any subspecialty. For clinical sessions, the proportion of female leaders exceeded the overall increase in cornea (20% cornea vs. 13% overall), neuro-ophthalmology (15% vs. 9%), and pediatrics (35% vs. 17%). Conclusions: Female representation among presenters at the AAO annual and subspecialty meetings increased between 2004 and 2019 for all subspecialties. For many subspecialties, there was a proportionally slower rate of increase in female representation among surgical session presenters and faster rate of increase for clinical sessions.
- 13 December 2022
- Published by Wiley in Acta Ophthalmologica
- Vol. 101 (4) , 449-456
Abdominal aortic aneurysm and exfoliation syndrome in Utah
PurposeA pilot study of electronic medical records (EMR) in Utah was undertaken to investigate exfoliation syndrome and exfoliation glaucoma (XFS/XFG) in abdominal aortic aneurysm (AAA) patients. In a subsequent retrospective cohort study of Utah XFS/XFG patients and population controls, the risk of AAA was examined. MethodsEMR of a statewide healthcare population were obtained from the Utah Population Database (UPDB) which links decades of medical records with Utah demographic and vital records data. In a pilot study, 7167 patients ages >= 40 years identified with AAA diagnosed from 1996 to 2015, based on International Classification of Diseases (ICD) version 9/10 codes, were included. A univariable hazards model was used to determine the risk of XFS/XFG in AAA patients. An XFS/XFG outcome based on ICD 9/10 codes in AAA patients and in 5:1 sex- and age-matched non-AAA controls was determined. A retrospective cohort of 3412 XFS/XFG patients ages >= 50 years diagnosed from 1996 to 2020 and 10 227 3:1 sex- and age-matched controls who underwent >= 1 dilated eye examination(s) were recently identified and updated diagnoses of AAA were obtained. Multivariable logistic regression was used to estimate AAA risk in XFS/XFG patients compared with controls. In a subset of XFS/XFG patients, chart reviews were conducted to confirm clinically diagnosed AAA. ResultsIn the AAA pilot, 20 patients (0.3%) and 118 controls (0.3%) developed XFS/XFG, respectively. We observed no increased risk of XFS/XFG in AAA patients compared with non-AAA-matched controls (HR = 0.99, 95% CI 0.6-1.6). Among XFS/XFG study patients and controls, 122 patients (3.6%) and 376 controls (3.7%) had an AAA diagnosis. We likewise observed no increased risk of AAA in XFS/XFG patients (OR = 0.97, 95% CI 0.8-1.2). In 14 XFS/XFG patients with an ICD 9/10 diagnosis of AAA who underwent chart review, a clinical diagnosis of AAA was confirmed in 9 patients (64.3%). ConclusionOur findings do not support an association between AAA and XFS/XFG.
- 13 December 2022
- Published by Wiley in Acta Ophthalmologica
- Vol. 101 (4) , 449-456
Abdominal aortic aneurysm and exfoliation syndrome in Utah
PurposeA pilot study of electronic medical records (EMR) in Utah was undertaken to investigate exfoliation syndrome and exfoliation glaucoma (XFS/XFG) in abdominal aortic aneurysm (AAA) patients. In a subsequent retrospective cohort study of Utah XFS/XFG patients and population controls, the risk of AAA was examined. MethodsEMR of a statewide healthcare population were obtained from the Utah Population Database (UPDB) which links decades of medical records with Utah demographic and vital records data. In a pilot study, 7167 patients ages >= 40 years identified with AAA diagnosed from 1996 to 2015, based on International Classification of Diseases (ICD) version 9/10 codes, were included. A univariable hazards model was used to determine the risk of XFS/XFG in AAA patients. An XFS/XFG outcome based on ICD 9/10 codes in AAA patients and in 5:1 sex- and age-matched non-AAA controls was determined. A retrospective cohort of 3412 XFS/XFG patients ages >= 50 years diagnosed from 1996 to 2020 and 10 227 3:1 sex- and age-matched controls who underwent >= 1 dilated eye examination(s) were recently identified and updated diagnoses of AAA were obtained. Multivariable logistic regression was used to estimate AAA risk in XFS/XFG patients compared with controls. In a subset of XFS/XFG patients, chart reviews were conducted to confirm clinically diagnosed AAA. ResultsIn the AAA pilot, 20 patients (0.3%) and 118 controls (0.3%) developed XFS/XFG, respectively. We observed no increased risk of XFS/XFG in AAA patients compared with non-AAA-matched controls (HR = 0.99, 95% CI 0.6-1.6). Among XFS/XFG study patients and controls, 122 patients (3.6%) and 376 controls (3.7%) had an AAA diagnosis. We likewise observed no increased risk of AAA in XFS/XFG patients (OR = 0.97, 95% CI 0.8-1.2). In 14 XFS/XFG patients with an ICD 9/10 diagnosis of AAA who underwent chart review, a clinical diagnosis of AAA was confirmed in 9 patients (64.3%). ConclusionOur findings do not support an association between AAA and XFS/XFG.
- 8 December 2022
- Published by Wiley in Acta Ophthalmologica
- Vol. 101 (5) , 478-484
Abdominal aortic aneurysm and exfoliation syndrome: A literature review comparing single site findings
Several studies have suggested a possible relationship between exfoliation syndrome (XFS) and abdominal aortic aneurysm (AAA). A systematic literature review was undertaken to investigate this potential association. The systematic literature review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines. Clear definitions of XFS and AAA were used to identify eligible studies via an unrestricted search of the PubMed interface from 1979 to October 31st, 2021. After review, 876 citations were gathered and evaluated for inclusion, from which 22 articles were included. Of these 22, 16 were excluded because they did not assess the relationship between AAA and XFS or provide primary data. Ultimately, six studies were included in this literature review. Half of the studies explored AAA prevalence in a population with or without XFS, and the other half explored the opposite. Three studies supported XFS as a risk factor for the development of AAA, and the other three found this relationship to be inconclusive. This systematic review revealed inconsistent results regarding an association between AAA and XFS. A large database study including XFS and AAA patients would be useful in further determining if an association does in fact exist.
- 8 December 2022
- Published by Wiley in Acta Ophthalmologica
- Vol. 101 (5) , 478-484
Abdominal aortic aneurysm and exfoliation syndrome: A literature review comparing single site findings
Several studies have suggested a possible relationship between exfoliation syndrome (XFS) and abdominal aortic aneurysm (AAA). A systematic literature review was undertaken to investigate this potential association. The systematic literature review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines. Clear definitions of XFS and AAA were used to identify eligible studies via an unrestricted search of the PubMed interface from 1979 to October 31st, 2021. After review, 876 citations were gathered and evaluated for inclusion, from which 22 articles were included. Of these 22, 16 were excluded because they did not assess the relationship between AAA and XFS or provide primary data. Ultimately, six studies were included in this literature review. Half of the studies explored AAA prevalence in a population with or without XFS, and the other half explored the opposite. Three studies supported XFS as a risk factor for the development of AAA, and the other three found this relationship to be inconclusive. This systematic review revealed inconsistent results regarding an association between AAA and XFS. A large database study including XFS and AAA patients would be useful in further determining if an association does in fact exist.
- Open Access
Exfoliation Syndrome and Exfoliation Glaucoma in the Navajo Nation
(1) Background: Exfoliation syndrome (XFS) is a common cause of secondary open angle glaucoma. In 1971, Faulkner et al. estimated the prevalence of XFS among 50 Navajo Nation residents as 38%. Given that XFS can cause irreversible blindness secondary to glaucoma (XFG), this study aims to identify the current prevalence of XFS among Navajo Nation residents within the Four Corners region of the U.S. (2) Methods: A retrospective chart review was conducted from 2016 to 2021 for patients aged 18 and older. All patients with XFS or XFG diagnosed by slit lamp exam were identified through chart review. (3) Results: Of the 1152 patient charts available for review, eight patients (11 eyes) were diagnosed with XFS with three patients (4 eyes) demonstrating concomitant XFG. Within this XFS population, 50% of the patients identified as male, with a mean age of 73 years. The overall prevalence of XFS was 0.7% and the overall prevalence of XFG was found to be 0.26%. The rate of XFG among patients with XFS was 37.5%. (4) Conclusion: Compared to Faulkner’s study of Navajo Nation residents in 1971, our findings show a considerably lower prevalence of XFS at 0.7%. We present the largest study to date of XFS among this population.
Open AccessExfoliation Syndrome and Exfoliation Glaucoma in the Navajo Nation
(1) Background: Exfoliation syndrome (XFS) is a common cause of secondary open angle glaucoma. In 1971, Faulkner et al. estimated the prevalence of XFS among 50 Navajo Nation residents as 38%. Given that XFS can cause irreversible blindness secondary to glaucoma (XFG), this study aims to identify the current prevalence of XFS among Navajo Nation residents within the Four Corners region of the U.S. (2) Methods: A retrospective chart review was conducted from 2016 to 2021 for patients aged 18 and older. All patients with XFS or XFG diagnosed by slit lamp exam were identified through chart review. (3) Results: Of the 1152 patient charts available for review, eight patients (11 eyes) were diagnosed with XFS with three patients (4 eyes) demonstrating concomitant XFG. Within this XFS population, 50% of the patients identified as male, with a mean age of 73 years. The overall prevalence of XFS was 0.7% and the overall prevalence of XFG was found to be 0.26%. The rate of XFG among patients with XFS was 37.5%. (4) Conclusion: Compared to Faulkner’s study of Navajo Nation residents in 1971, our findings show a considerably lower prevalence of XFS at 0.7%. We present the largest study to date of XFS among this population.